Press Releases

Date Title and Summary Additional Formats
Toggle Summary Minerva Neurosciences Announces Completion of FDA Review of Investigational New Drug Application for MIN-202 and Plans for First U.S.-Based Clinical Trial
Bioavailability Study in U.S. for Investigational Therapy in Development for Treatment of Insomnia to be Initiated
View HTML
Toggle Summary Minerva Neurosciences to Present at Baird 2014 Health Care Conference View HTML
Toggle Summary Mark S. Levine Joins Minerva Neurosciences as VP and General Counsel View HTML
Toggle Summary Minerva Neurosciences Reports Second Quarter 2014 Financial Results View HTML
Toggle Summary Minerva Neurosciences to Host Second Quarter 2014 Financial Results Webcast and Conference Call View HTML
Toggle Summary Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer View HTML
Toggle Summary Minerva Neurosciences To Ring NASDAQ Stock Market Closing Bell On July 7, 2014 View HTML
Toggle Summary Minerva Neurosciences Announces Pricing of Initial Public Offering View HTML